Beijing, China

Zihan MA

This inventor holds 1 USPTO granted patent. Top assignee: Beijing Kimway Biotech Co. Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zihan MA. Retrieved from https://idiyas.com/inventor/zihan-ma-c4o74v2h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zihan MA: Innovator in Anti-Atherosclerosis Research

Introduction

Zihan MA is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the area of anti-atherosclerosis research. His innovative work has the potential to impact the treatment of related diseases.

Latest Patents

Zihan MA holds a patent for "Immunogenic Peptide Fragments of Metalloprotease ADAMTS-7 and Uses Thereof in Anti-Atherosclerosis and Related Diseases." This patent highlights his focus on developing therapeutic solutions that target critical pathways in atherosclerosis.

Career Highlights

Zihan MA is associated with Beijing Kimway Biotech Co. Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a drive to improve health outcomes through scientific discovery.

Collaborations

Zihan MA collaborates with talented colleagues, including Wei Kong and Yi Fu. Together, they work towards achieving breakthroughs in their respective fields.

Conclusion

Zihan MA is a dedicated inventor whose work in anti-atherosclerosis research exemplifies the importance of innovation in biotechnology. His contributions are paving the way for new therapeutic approaches to combat related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…